Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Maximum reliability for read across-studies Critical study in OECD risk assessment, 2004.

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
No information
Author:
Onodera H et.al.
Year:
1978
Bibliographic source:
Eisei Shikenjo Hokoku 96: 47-55
Reference Type:
publication
Title:
SIDS Initial Assessment Report for 13th SIAM (Bern, 7th – 9th November 2001) on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol, CAS Nos. 65-85-0, 532-32-1, 582-25-2, and 100-51-6
Author:
OECD
Year:
2004
Bibliographic source:
http://webnet.oecd.org/HPV/UI/SIDS_Details.aspx?key=9d081a2b-4582-464a-99d7-27749e8b324a&idx=0

Materials and methods

Principles of method if other than guideline:
Study with pregnant Wistar rats, dosed with 700, 1400, 2800, 5600 mg/kg sodium benzoate in the diet during the entire gestation; examinations included body weight, food consumption, number of life and dead fetuses, visceral and skeletal investigations of fetuses.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium benzoate
EC Number:
208-534-8
EC Name:
Sodium benzoate
Cas Number:
532-32-1
Molecular formula:
C7H6O2.Na
IUPAC Name:
sodium benzoate
Details on test material:
sodium benzoate

Test animals

Species:
rat
Strain:
Wistar

Administration / exposure

Route of administration:
oral: feed
Duration of treatment / exposure:
during entire gestation period
Frequency of treatment:
continuously in diet
Control animals:
yes
Details on study design:
Study with pregnant Wistar rats, dosed with 700, 1400, 2800, 5600 mg/kg sodium benzoate in the diet during the entire gestation; examinations included body weight, food consumption, number of life and dead fetuses, visceral and skeletal investigations of fetuses.

Results and discussion

Results: maternal animals

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
1 400 mg/kg bw/day (nominal)
Basis for effect level:
other: maternal toxicity

Results (fetuses)

Effect levels (fetuses)

Dose descriptor:
NOAEL
Effect level:
1 400 mg/kg bw/day (nominal)
Basis for effect level:
other: teratogenicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

No statistical difference in organ and bone abnormalities of fetuses between experimental groups and controls; growth of treated offsprings was similar to controls in rats dosed with 1400 mg/kg/day; reduced food intake and decreased body weight of the pregnant rats especially in the 5600 mg/kg group; 100% perinatal death rate; organ abnormalities of fetuses involved eye, brain and kidneys, in addition abnormalities of the skeletal system were found in rats dosed with >2800 mg/kg/day. The authors concluded that the effects on the dams and fetuses at the 2800 and 5600 levels were due to reduced maternal feed intake in these groups, leading to malnutrition.

Applicant's summary and conclusion

Executive summary:

Cited from OECD 2004: "A study using pregnant Wistar rats, dosed with 700, 1400, 2800, 5600 mg/kg sodium benzoate in the diet during the entire gestation showed no statistical difference in organ and bone abnormalities of fetuses between experimental groups and controls; growth of treated offsprings was similar to controls in rats dosed with 1400 mg/kg/day; reduced food intake and decreased body weight of the pregnant rats especially in the 5600 mg/kg group; 100% perinatal death rate; organ abnormalities of fetuses involved eye, brain and kidneys, in addition abnormalities of the skeletal system were found in rats dosed with >2800 mg/kg/day. The authors concluded that the effects on the dams and fetuses at the 2800 and 5600 levels were due to reduced maternal feed intake in these groups, leading to malnutrition, NOAEL Maternal toxicity: 1400 mg/kg bw, NOAEL Teratogenicity: 1400 mg/kg bw."

(Onodera et al. 1978, OECD 2004)